ABSTRACT
Background@#Growth hormone has been used as an adjunct in ovarian stimulation of IVF cycles for the past three decades. However, the exact mechanism of its role in improving oocyte quality has not been thoroughly investigated. Although a clear indication for GH co-treatment is in infertile women with GH deficiency, GH has been given mostly to poor ovarian responders.@*Method@#This paper is a review of the most recent published data on the role of GH supplementation in improving oocyte quality in younger women who are suboptimal or unexpected poor responders to standard ovarian stimulation.@*Results@#Retrospective cohort and randomized trials demonstrated an improvement in oocyte quality through morphological parameters, mitochondrial function, biomarkers, GH receptors, insulin growth factor, markers of oxidative stress, mature oocytes, good quality embryos, implantation rate, clinical pregnancy and live birth.@*Conclusion@#Current data suggest GH supplementation may improve oocyte and embryo qualities, endometrial receptivity, clinical pregnancy and live birth. However, better quality evidence is needed before a recommendation can be made for GH supplementation to be given to infertile women who are suboptimal or poor ovarian responders.
Subject(s)
Growth Hormone , Insulin-Like Growth Factor IABSTRACT
BACKGROUND: The assessment of oocyte quality is, nowadays, a major challenge in aquaculture, oocyte cryopreservation, and environmental science. Oocyte quality is a determining factor in fertilization and embryo development; however, there is still a lack of rapid and sensitive cellular markers for its assessment. Currently, its estimation is pre-dominantly based on morphological analysis, which is subjective and does not consistently reflect the developmental competence of the oocytes. Despite several recent studies investigating molecular markers related to oocyte quality, methods currently available for their determination pose various technical challenges and limitations. In this study, we developed a novel approach based on fluorescence spectroscopy to assess different intrinsic physiological parameters that can be employed to evaluate egg quality in marine invertebrates that are widely used as animal models such as sea urchins and mussels. RESULTS: Different physiological parameters, such as viability, mitochondrial activity, intracellular ROS levels, plasma membrane lipid peroxidation, and intracellular pH, for egg quality evaluation have been successfully assessed in sea urchins and mussels by using specific fluorescent dyes and detecting the fluorescent signals in eggs through fluorescence spectroscopy. CONCLUSIONS: Based on our findings, we propose these physiological markers as useful predictors of egg quality in marine invertebrates; they can be estimated rapidly, selectively, and sensitively by employing this novel approach, which, due to the speed of analysis, the low cost, and easy use can be considered a powerful analytical tool for the egg quality assessment.
Subject(s)
Animals , Oocytes/metabolism , Embryonic Development , Sea Urchins , Spectrometry, Fluorescence , Cryopreservation/methodsABSTRACT
Endometriosis (EMS) is one of the most prevalent causes for female infertility. Herein, we investigated the effect of the repaglinide (RG), L-carnitine (LC), and bone marrow mesenchymal stem cell-conditioned medium (BMSC-CM) supplementation during in vitro maturation (IVM) on the quality, maturation, and fertilization rates, as well as embryonic quality and development of oocytes derived from normal and EMS mouse model. Immature oocytes were collected from two groups of normal and EMS-induced female NMRI mice at 6-8 weeks of age. Oocytes were cultured in IVM medium unsupplemented (control group), or supplemented with 1 M RG, 0.3 and 0.6 mg/mL LC, and 25 and 50% BMSC-CM. After 24 h of oocyte incubation, IVM rate and antioxidant status were assessed. Subsequently, the rates of fertilization, cleavage, blastulation, and embryonic development were assessed. Our results demonstrated that supplementation of IVM medium with LC and BMSC-CM, especially 50% BMSC-CM, significantly enhanced IVM and fertilization rates, and markedly improved blastocyst development and total blastocyst cell numbers in EMS-induced mice compared to the control group (53.28±0.24 vs 18.09±0.10%). Additionally, LC and BMSC-CM were able to significantly modulate EMS-induced nitro-oxidative stress by boosting total antioxidant capacity (TAC) and mitigating nitric oxide (NO) levels. Collectively, LC and BMSC-CM supplementation improved oocyte quality and IVM rates, pre-implantation developmental competence of oocytes after in vitro fertilization, and enhanced total blastocyst cell numbers probably by attenuating nitro-oxidative stress and accelerating nuclear maturation of oocytes. These outcomes may provide novel approaches to refining the IVM conditions that can advance the efficiency of assisted reproductive technologies in infertile couples.
ABSTRACT
ABSTRACT Objective: A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) and ADAMTS-5 normal expression levels are essential for ovulation and subsequent fertilization. The objective of the present study was to assess expression pattern of these genes in cumulus cells (CCs) taken from patients with polycystic ovary syndrome (PCOS) and to investigate any possible relationship with the oocyte quality. Subjects and methods: ADAMTS-4 and -5 expression levels within CCs containing oocytes at the metaphase II (MII) and germinal vesicle (GV) stages, taken from 35 patients with PCOS and 35 women with normal ovarian function, were investigated using RT-qPCR. Moreover, possible correlations between ADAMTS-4, ADAMTS-5, and progesterone receptors (PRs) expression as well as oocyte quality were evaluated. Results: ADAMTS-4 and -5 expression levels were dramatically diminished in the CCs of the PCOS patients when compared to the controls. ADAMTS-4 and -5 expression levels were correlated with each other and with the oocyte quality. Furthermore, lower expression levels of ADAMTS-4 and -5 in the PCOS patients were strongly correlated with the diminished PRs expression levels. Conclusions: Downregulation of ADAMTS-4 and -5 in the human CCs of the PCOS patients correlated with the decline in the PRs expression, and impaired oocyte quality may cause lower oocyte recovery, maturation, and fertilization rate.
Subject(s)
Female , Humans , Oocytes , Polycystic Ovary Syndrome , Polycystic Ovary Syndrome/genetics , ADAMTS4 Protein/genetics , ADAMTS5 Protein/genetics , Down-RegulationABSTRACT
Abstract Objective To investigate whether follicular fluid (FF) from infertile women with mild endometriosis (ME) alters in vitro bovine embryo development, and whether the antioxidants N-acetyl-cysteine (NAC) and/or L-carnitine (LC) could prevent such damages. Methods Follicular fluid was obtained from infertile women (11 with ME and 11 control). Bovine oocytes were matured in vitro divided in: No-FF, with 1% of FF from control women (CFF) or ME women (MEFF); with 1.5mM NAC (CFF + NAC, MEFF + NAC), with 0.6mg/mL LC (CFF + LC, MEFF + LC), or both antioxidants (CFF + NAC + LC, MEFF + NAC + LC). After in vitro fertilization, in vitro embryo culture was performed for 9 days. Results A total of 883 presumptive zygotes were cultured in vitro. No differences were observed in cleavage rate (p = 0.5376) and blastocyst formation rate (p = 0.4249). However, the MEFF group (12.5%) had lower hatching rate than the No-FF (42.1%, p = 0.029) and CFF (42.9%, p = 0.036) groups. Addition of antioxidants in the group with CFF did not alter hatching rate (p ≥ 0.56), and in groups with MEFF, just NAC increased the hatching rate [(MEFF: 12.5% versus MEFF + NAC: 44.4% (p = 0.02); vs MEFF + LC: 18.8% (p = 0.79); versus MEFF + NAC + LC: 30.8% (p = 0.22)]. Conclusion Therefore, FF from infertile women with ME added to medium of in vitro maturation of bovine oocytes impairs hatching rate, and NAC prevented these damages, suggesting involvement of oxidative stress in worst of oocyte and embryo quality of women with ME.
Resumo Objetivo Investigar se o fluido folicular (FF) de mulheres inférteis com endometriose leve (ME, na sigla eminglês) altera o desenvolvimento in vitro de embriões bovinos, e se os antioxidantes N-acetil-cisteína (NAC) e/ou L-carnitina (LC) poderiam prevenir possíveis danos. Métodos O FF foi obtido de mulheres inférteis (11 com ME e 11 controles). Oócitos bovinos foram maturados in vitro divididos em: sem FF (No-FF), com 1% de FF de mulheres controle (CFF) ou mulheres comME (MEFF); com 1,5mMde NAC (CFF + NAC, MEFF + NAC), com 0,6mg/mL de LC (CFF + LC, MEFF + LC), ou ambos antioxidantes (CFF + NAC + LC, MEFF + NAC + LC). Depois da fertilização in vitro, o cultivo in vitro de embriões foi realizado por 9 dias. Resultados Um total de 883 zigotos presumidos foram cultivados in vitro. Nenhuma diferença foi observada na taxa de clivagem (p = 0,5376) e na taxa de formação de blastocistos (p = 0,4249). Entretanto, o grupo MEFF (12.5%) teve menor taxa de eclosão de blastocistos do que os grupos No-FF (42,1%, p = 0,029) e CFF (42,9%, p = 0,036). Adição de antioxidantes no grupo comCFF não alterou a taxa de eclosão (p ≥ 0.56), e nos grupos com MEFF, somente a NAC aumentou a taxa de eclosão [(MEFF: 12.5% versus MEFF + NAC: 44.4% (p = 0.02); versus MEFF + LC: 18.8% (p = 0.79); versus MEFF + NAC + LC: 30.8% (p = 0.22)]. Conclusão Portanto, o FF de mulheres inférteis com ME adicionado ao meio de maturação in vitro de oócitos bovinos prejudica a taxa de closão embrionária, e a NAC preveniu esses danos, sugerindo o envolvimento do estresse oxidativo na piora da qualidade oocitária e embrionária de mulheres com ME.
Subject(s)
Animals , Female , Cattle , Endometriosis , Infertility, Female , Oocytes , Follicular Fluid/metabolism , Embryonic Development , Disease Models, AnimalABSTRACT
Objective To investigate whether the metabolites in follicular fluid can be used as indicators for predicting oocyte quality and embryos early development in patients with polycystic ovary syndrome (PCOS). Methods The study subjects were divided into four groups: lean control (LC) 30 cases, overweight (OW) 13 cases, lean PCOS (LP) 26 cases, and overweight PCOS (OP) 26 cases based on the Chinese criteria for body mass index (BMI) categories. The metabolic variance of follicular fluid from PCOS and controls was performed by liquid chromatography-mass spectrometry (LC-MS), and clinical characteristics, oocyte outcomes and differences of metabolites in follicular fluid of those patients have been compared by ANOVA. Furthermore, Pearson's correlation analysis was used to explore the correlation between oocyte fertilization rate, top-quality embryos rate and follicular metabolites. Results Compared to the LC group, oocytes retrieved and top-quality embryos rate were significantly increased, while the mature oocytes rate and fertilization rate decreased significantly in the OP group. A total of 236 metabolites were identified and quantified by metabolomics in follicular fluid. Compared with LC and OP groups, 19 metabolites showed statistically significant differences in PCOS group. Additionally, 7 metabolites were significant correlated with the fertilization rate or top-quality embryo rate respectively, most of which were lysophospholipids. Conclusion Several metabolites in the follicular fluid are significantly different between PCOS and healthy women. Among these, lysophospholipids are crucial for oocyte quality and early embryonic development, may serve as potential markers to evaluate the oocyte quality in PCOS patients.
ABSTRACT
Abstract Background: Oocyte quality and maturation are influenced by protein supplementation. Objective: To evaluate the influence of fetal bovine serum (FBS) and bovine serum albumin (BSA) concentrations on the recovery and in vitro maturation (IVM) of bovine oocytes. Methods: The study was divided into Stage 1 (oocyte recovery), and Stage 2 (IVM). In the first stage, three experiments were conducted according to the recovery (R) medium used: (R1) 10 vs. 20% FBS; (R2) 5 vs. 10% BSA; and (R3) the best results from R1, R2, and the combination of FBS+BSA (5+5%). Within the second stage, the maturation medium was supplemented according to three experiments: (M1) 5 vs. 10% FBS; (M2) 0.4 vs. 0.8% BSA; and (M3) better results of M1, M2, and the combination of FBS+BSA (5+0.8%). Results: In Stage 1 (R1 and R2), the media with 10% FBS and 10% BSA showed better oocyte quality results and were defined for experiment R3. In R3, the 10% FBS and the combination of FBS+BSA (5+5%) allowed recovery of better-quality oocytes. In Stage 2 (M1 and M2), media with both levels of FBS (5 and 10%) and 0.8% BSA were defined as better according to the maturation and viability rates of cumulus cells, so they were defined for experiment M3. In M3, no difference was noted among the supplements. Conclusions: For oocyte recovery, 10% FBS and the combination of FBS+BSA (5+5%) can be used to obtain immature oocytes. For the in vitro maturation, FBS (both levels, 5 and 10%) and BSA (0.8%) can be used alone or in combination.
Resumen Antecedentes: La calidad y maduración de los ovocitos son influenciados por la suplementación proteica. Objetivo: Evaluar la influencia de concentraciones de suero fetal bovino (FBS) y albúmina sérica bovina (BSA) en la recuperación y maduración in vitro (IVM) de ovocitos bovinos. Métodos: El estudio se dividió en Etapa 1 (recuperación de ovocitos) y Etapa 2 (IVM). En la primera etapa, tres experimentos se realizaron de acuerdo con el medio de recuperación: (R1) 10 vs. 20% FBS; (R2) 5 vs. 10% BSA; y (R3) los mejores resultados de R1, R2 y la combinación de FBS+BSA (5+5%). En la segunda etapa, el medio de maduración fue suplementado para tres experimentos: (M1) 5 vs. 10% FBS; (M2) 0,4 vs. 0,8% BSA; y (M3) mejores resultados de M1, M2 y la combinación de FBS+BSA (5+0,8%). Resultados: En la Etapa 1 (R1 y R2), los medios con 10% FBS y 10% BSA mostraron mejores resultados de calidad oocitaria y fueron definidos para el experimento R3. En R3, 10% FBS y la combinación de FBS+BSA (5+5%) permitieron la recuperación de ovocitos de mejor calidad. En la Etapa 2 (M1 y M2), los medios con ambos niveles de FBS (5 y 10%) y 0,8% de BSA se definieron como mejores de acuerdo con las tasas de maduración y viabilidad de las células del cumulus, por lo que se definieron para el experimento M3. En M3, no se observó diferencia entre los suplementos. Conclusiones: Para la recuperación de ovocitos, se puede utilizar 10% de FBS y la combinación de FBS+BSA (5+5%) para obtener ovocitos inmaduros. Para la maduración in vitro, FBS (ambos niveles, 5 y 10%) y BSA (0,8%) se pueden usar solos o en combinación.
Resumo Antecedentes: A qualidade e a maturação de oócitos são influenciadas pela suplementação proteica. Objetivo: Avaliar a influência de concentrações de soro fetal bovino (FBS) e albumina sérica bovina (BSA) sobre a recuperação e maturação in vitro (IVM) de oócitos bovinos. Métodos: O estudo foi dividido em Etapa 1 (recuperação de oócitos) e Etapa 2 (IVM). Na primeira etapa, três experimentos foram realizados de acordo com o meio de recuperação: (R1) 10 vs. 20% FBS; (R2) 5 vs. 10% BSA; e (R3) melhores resultados de R1, R2 e a combinação de FBS+BSA (5+5%). Na segunda etapa, o meio de maturação foi suplementado de acordo com três experimentos: (M1) 5 vs. 10% FBS; (M2) 0,4 vs. 0,8% BSA; e (M3) melhores resultados de M1, M2 e a combinação de FBS+BSA (5+0,8%). Resultados: Na Etapa 1 (R1 e R2), os meios com 10% FBS e 10% BSA mostraram melhores resultados de qualidade oocitária e foram definidos para o experimento R3. Em R3, 10% FBS e a combinação de FBS+BSA (5+5%) permitiram a recuperação de oócitos de melhor qualidade. Na segunda etapa (M1 e M2), meios com ambos os níveis de FBS (5 e 10%) e 0,8% BSA foram definidos como os melhores de acordo com as taxas de maturação e viabilidade de células do cumulus, então foram definidos para o experimento M3. No M3, não houve diferença entre os suplementos. Conclusões: Para a recuperação oocitária, 10% FBS e a combinação de FBS+BSA (5+5%) podem ser usados para obter oócitos imaturos. Para maturação in vitro, FBS (ambos os níveis, 5 e 10%) e BSA (0,8%) podem ser usados sozinhos ou em combinação.
ABSTRACT
Objetivou-se com este trabalho avaliar a influência do horário de aplicação e da variedade genética de fêmeas submetidas à indução com hCG. O experimento foi realizado nos meses de julho e agosto de 2012. Utilizou-se delineamento inteiramente ao acaso, com esquema fatorial 2x4x2 (duas variedades, quatro horários de aplicação, com e sem hCG), sendo quatro repetições para os tratamentos controle e seis para induzidos com hCG. Foram utilizadas 40 fêmeas das variedades GIFT e UFLA, microchipadas, alojadas em um sistema com recirculação de água. Foram utilizados quatro horários de aplicação: seis; 12; 18 e 24 horas. A dosagem de hCG foi de 5UI/grama de peso de peixe, dividida em duas aplicações. A extrusão dos ovócitos foi realizada 720 horas-graus após a última aplicação, sendo observado o número de animais de cada tratamento que apresentaram desova. Os dados obtidos foram submetidos à análise de variância, e as médias comparadas pelo teste SNK a 5% de significância. A indução com hCG proporcionou melhores (P<0,05) resultados paras as variáveis: índice de desova (ID), fecundidade absoluta relativa ao comprimento (FARC) e peso de desova (PD), independentemente da variedade utilizada. A variedade UFLA não foi influenciada pelo horário de aplicação (P>0,05). Já a GIFT apresentou maior ID (P<0,05) quando a indução hormonal foi realizada às 24h em relação à aplicação realizada às 18h. O diâmetro do ovócito da variedade UFLA é maior do que o da GIFT (P<0,05). Ao se observar o grupo controle, verificou-se que a variedade UFLA apresentou maior porcentagem de ovócitos com posição periférica de vesícula germinativa (P<0,05) em relação à GIFT. A indução hormonal com hCG foi influenciada pela variedade e pelo horário de aplicação.
The aim of this work was to evaluate the influence of the application time and genetic variability of females submitted to hormonal induction with hCG. The experiment was performed in the months of July and August 2012. We used a completely randomized design, with a 2x4x2 (two varieties, four application times, with or without hCG) factorial scheme, with four replicates for the control treatments and six replicated for those with hCG induction. Forty females of the GIFT and UFLA varieties, with microchips, were housed in a water recirculation system. Four application times were used: 6; 12; 18 and 24 hours. The hCG dosage was 5UI/gram of fish, divided into two applications. Oocyte extrusion was performed 720 hours after the last application, observing the number of animals in each treatment which presented spawning. The obtained data were submitted to variance analysis and the means compared by the SNK test at 5% significance. The induction with hCG provided better (P<0.05) results for the variables: spawning index (SI), absolute fecundity relative to length (AFRL) and spawning weight (SW), regardless of the variety used. The UFLA variety was not influenced by the time of application (P>0.05), while GIFT presented higher SI (P<0.05) when the hormonal induction was performed at 24 h in relation to the application performed at 18 h. The diameter of the oocytes of the UFLA variety was larger than that of the GIFT variety (P<0.05). Observing the control group, the UFLA variety presented a higher percentage of oocytes with peripheral position of the germinal vesicle (P<0.05) in relation to GIFT. The hormonal induction with hCG was influenced by the variety and the time of application.
Subject(s)
Animals , Fertility , Growth Hormone , Reproduction , Tilapia , Fishes , OocytesABSTRACT
Objective To investigate the effect of electroacupuncture (EA) on oocyte quality in patients with polycystic ovary syndrome (PCOS) undergoing in-vitro-fertilization and embryo transfer (IVF-ET).Method Totally 217 patients with PCOS undergoing IVF-ET were randomized into two groups by the random number table, 119 patients in an EA group and 98 in a control group. In addition to the long-term ovarian hyperstimulation given to the two groups, electroacupuncture was involved in the intervention in the EA group. The spindle, quality of eggs, and pregnancy result were observed and compared.Result The high-quality embryo rate was significantly higher in the EA group than the control group (P<0.05), and compared to the control group, the pregnancy rate was 8.36% higher in the EA group; it’s found that the number of eggs with spindle located between 11 and 1 o’clock was in a significant positive correlation with the level of E2 on the HCG administration day and the high-quality embryo rate (P<0.01); the EA group had a markedly higher ratio of eggs with spindle located between 11 and 1 o’clock compared to the control group (P<0.05); electroacupuncture markedly reduced the dosage and duration of using Gn in the PCOS patients (P<0.05). Conclusion It’s proven the relation between spindle and the quality of eggs; electroacupuncture can enhance the quality of eggs and the pregnancy rate in the PCOS patients.
ABSTRACT
ObjectiveTo observe the effect of transcutaneous acupoint electrical stimulation (TAES) on the ovariangranulosa cell apoptosis-related proteins, Bcl-2 and Bax, as well as the oocyte quality in theolder women with kidney deficiency receiving in vitro fertilization-embryo transfer (IVF-ET).MethodSixty-six older women with kidney deficiency who were receiving IVF-ET because of the fallopian tube factor were randomized into a treatment group (intervened by TAES) and a control group (intervened by sham acupuncture), 33 in each group. The kidney-deficiency syndrome score, HCG E2/follicle count per day, excellent follicle rate, excellent embryo rate, and clinical pregnancy rate were observed and compared between the two groups; Western blot was used to detect the expression of protein Bcl-2 and Bax.ResultCompared to the control group, the treatment group had significant improvement in kidney-deficiencysymptoms (P0.05). The expression of Bcl-2 and Bax proteins were markedlycorrelatedwith IVF-related indexes (P<0.05).ConclusionTAES can improve the kidney-deficiency symptoms and the quality of oocyte and embryo inolder women; this action is possibly related to the regulation of expression of the cell apoptosis-related protein Bcl-2 and Bax, as well as the decrease ofgranulosecell apoptosis.
ABSTRACT
Objetivo: Menores taxas de gestação em portadoras de endometriose submetidas a técnicas de reprodução assistida podem estar relacionadas à piora da qualidade oocitária. A análise da expressão gênica em células do cumulus (CC) pode fornecer biomarcadores passíveis de predizer a qualidade gamética. O objetivo deste estudo foi comparar os níveis da expressão do gene CYP19A1 em CC de mulheres inférteis com endometriose mínima/leve (I/II) e controles inférteis. Método: Foram selecionadas pacientes com infertilidade por endometriose pélvica inicial e por fator masculino e/ou tubário (grupo controle), submetidas à estimulação ovariana controlada para injeção intracitoplasmática de espermatozoide (ICSI). Imediatamente após a captação oocitária, CC foram isoladas e armazenadas. Foi realizada a quantificação da expressão do gene CYP19A1 nas CC por meio de PCR-Real Time. Resultados: Foram isoladas CC de 23 mulheres inférteis com endometriose I/II e de 41 controles. Observou-se expressão significativamente menor do gene CYP19A1 em CC de mulheres inférteis com endometriose I/II (0,56 ± 0,17) quando comparadas às controles (0,15 ± 0,04) (p = 0,043). Conclusões: A menor expressão do gene CYP19A1 em CC de mulheres inférteis com endometriose pélvica em estágios iniciais pode mediar a piora da qualidade oocitária, abrindo novas perspectivas no entendimento da etiopatogênese da infertilidade relacionada à doença.
Objective: Lower pregnancy rate in women with endometriosis submitted to assisted reproductive techniques might be related to poor oocyte quality. The analysis of the expression of the genes in cumulus cells (CC) might provide biomarkers that can predict gamete quality. The main objective of the present study was to compare the levels of the expression of the gene CYP19A1 in CC of infertile women with minimal and mild (I/II) endometriosis and infertile controls. Method: There were selected patients with infertility caused by initial pelvic endometriosis and by male/tubal factor (control group), submitted to controlled ovarian stimulation to ICSI. Immediately after the oocyte retrieval, CC were isolated and stored. Quantification of the expression of the gene CYP19A1 in CC was performed using PCR-real time.Results: CC were isolated from 23 infertile women with endometriosis I/II and 41 from control. Significant lower expression of the gene CYP19A1 in CC was observed in infertile women with endometriosis I/II (0.56 ± 0.17) when compared to control (0.15 ± 0.04) (p = 0,043). Conclusions: The lower expression of the gene CYP19A1 in CC of infertile women with pelvic endometriosis in initial stages might mediate the poor oocyte quality, opening new perspectives on the understanding of the etiopathogenesis of infertility related to the disease.
Subject(s)
Humans , Female , Aromatase , Endometriosis , Infertility, Female , OocytesABSTRACT
The effects of selenium (Se) in Jersey cows' diet on the aspiration of oocytes and production of embryos in vitro were studied. Groups with five Jersey cows received 3.2mg or 9.6mg Se daily, provided in the feed concentrate. Six follicular aspirations were carried out every 15 days, using only the last 5. The oocytes were classified, and standard procedures were carried out for maturation, fertilization and cultivation. The total number of oocytes (35.11±2.65 vs 23.10±2.16) and degree 1 oocytes (11.61±2.65 vs 4.75±0.97) were higher in the group that received 9.6mg Se and the quantity of naked oocytes (3.23±0.87 vs 6.22±1.18) was lower in this group. The aspirated oocytes from the cows treated with 9.6mg Se/day resulted in higher (P<0.05) embryo production 21.98±2.37 vs 13.12±1.59). No difference was observed in serum Se concentration between the two groups. It is recommended that the daily diet be supplemented with 100g mineral salt containing 9.6mg Se, since this rate rendered a larger production of oocytes, higher quantity of degree 1 oocytes and greater production of embryos in the process of in vitro fertilization.
Avaliou-se o efeito do selênio (Se) adicional na dieta de vacas Jersey na aspiração de oócitos e produção de embriões in vitro. Dez vacas Jerseys receberam 3,2mg de Se por dia ou 9,6mg, vinculado ao concentrado. Realizaram-se seis aspirações foliculares, com intervalo médio de 15 dias, aproveitando as cinco últimas. Os oócitos foram classificados e realizaram-se os procedimentos padrões de maturação, fertilização e cultivo in vitro. O total de oócitos, 35,11±2,65 vs 23,10±2,16, e oócitos de qualidade 1, 11,61±1,58 vs 4,75±0,97, foram mais elevados no grupo que recebeu 9,6mg de Se e a quantidade de oócitos desnudos mais baixa, 3,21±0,87 vs 6,22±1,18. A produção de embriões foi maior no grupo tratado com 9,6mg de Se/vaca/dia, 21,98±2,37 vs 13,12±1,59. Não se observou diferença na concentração de Se no soro entre os dois grupos. Conclui-se que é possível recomendar o fornecimento de 100g de sal mineral, contendo 9,6mg de Se, adicionado à dieta, pois resultou em maior produção de oócitos, maior quantidade de oócitos de grau 1 e maior produção de embriões no processo de fecundação in vitro.
Subject(s)
Animals , Cattle , Fertilization in Vitro/veterinary , Oocytes/metabolism , In Vitro Oocyte Maturation Techniques/veterinary , Selenium , Infant Nutritional Physiological PhenomenaABSTRACT
PURPOSE: To investigate the direct relationship between the follicular fluid (FF) level of soluble human leukocyte antigen G (HLA-G) and fertilizability of the corresponding oocyte as well as the morphological quality of the corresponding embryo. MATERIALS AND METHODS: Sixty-three patients were stimulated with recombinant FSH combined with gonadotropin-releasing hormone (GnRH) agonist long (n=5) or antagonist protocol (n=58) for standard in vitro fertilization (IVF). At the time oocyte retrieval, follicular fluid was obtained from single dominant follicle in 63 patients, and the level of soluble HLA-G was measured by sandwich enzyme-liked immunosorbent assay (ELISA). Normal fertilization and individual embryo quality were evaluated, and were graded to four categories by morphological criteria (the embryo with symmetrical blastomeres and no fragmentation were assigned as grade A). Good-quality embryo was defined as those with grade A or B. RESULTS: Soluble HLA-G was not detected in 15 FF samples. In the group with positive FF soluble HLA-G (sHLA-G) (n=48), high levels of sHLA-G (>117.758 U/mL) could predict the failure of fertilization with statistical significance {area under the curve (AUC) 0.676, 95% confidence interval (CI) 0.525-0.804}. However, the FF sHLA-G level was not related with the formation of good-quality embryo. CONCLUSION: High level of FF sHLA-G could predict the fertilization failure of the corresponding oocyte, but was not related with the formation of good-quality embryo.
Subject(s)
Adult , Female , Humans , Enzyme-Linked Immunosorbent Assay , Follicular Fluid/metabolism , HLA-G Antigens/metabolism , Oocytes/cytology , Ovarian Follicle/cytologyABSTRACT
OBJECTIVE: To estimate the efficacy of recombinant human follicle stimulating hormone (rFSH) versus highly purified urinary human FSH (uFSH) in women undergoing controlled ovarian hyperstimulation (COH) for in vitro fertilization and embryo transfer (IVF-ET). METHODS: From 1 January 2001 to 31 August 2001, A total of 254 cycles from 241 patients who attended infertility clinic at Samsung cheil hospital was enrolled in this study. With pituitary down regulation using GnRH agonist by short protocol, rFSH (Puregon(R), Organon, Netherlands) was administered in 131 cycles and uFSH (Metrodin-HP(R), Serono, Switzerland) was administered in 123 cycles. We analyzed ovarian response, pregnancy rate, live birth rate, oocyte quality and embryo quality. RESULTS: The clinical characteristics of two groups were not different. Total FSH dosages (1322.3+/-526.2 IU versus 2124.4+/-881.9 IU, p<0.001) and dosages per retrieved oocyte (90.6+/-36.0 IU versus 138.0+/-57.2 IU, p<0.001) were significantly lower in rFSH group than uFSH group. Clinical pregnancy rate and live birth rate of two groups were not significantly different. The rate of good quality oocyte (Grade I and II) from retrieved oocytes was higher in rFSH group (68.2% versus 64.8%, p=0.024), but after preincubating oocytes for 4 to 6 hours and removing cumulus cells in intracytoplasmic sperm injection (ICSI) cycles, nuclear maturity of oocytes were not significantly different. The quality of transferred embryos were not significantly different too. CONCLUSION: rFSH offered more effective ovarian response in COH and better quality of retrieved oocytes, compared with uFSH.